Some Aspects of Postoperative Management of Patients with Ovarian Cancer after Cytoreductive Surgery Using Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

The objective. Analysis of the course of the postoperative period and number of complications in patients with ovarian cancer during cytoreductive operations with hyperthermic intraoperative intra-abdominal chemotherapy.Subjects and Methods. We assessed the number of bed-days, the volume of infusion...

Full description

Bibliographic Details
Published in:	Вестник анестезиологии и реаниматологии
Main Authors:	D. D. Morikov, V. I. Gorbachev, A. G. Pavlov, V. V. Dvornichenko, A. V. Shelekhov, N. D. Morikov, S. I. Radostev
Format:	Article
Language:	Russian
Published:	New Terra Publishing House 2022-05-01
Subjects:	ovarian cancer acute kidney injury leukopenia cytoreductive surgery (crs) hyperthermic intraperitoneal chemotherapy (hipec) postoperative period
Online Access:	https://www.vair-journal.com/jour/article/view/647

Similar Items

Anesthesiological support of cytoreducative operations using hyperthermic intraperitoneal chemotherapy (hipec) in patients with ovaryan cancer
by: D. D. Morikov, et al.
Published: (2019-11-01)

The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
by: Guyu Zhang, et al.
Published: (2019-04-01)

High intra-abdominal pressure during hyperthermic intraperitoneal chemotherapy (HIPEC) following cytoreductive surgery (CRS) for peritoneal surface malignancies
by: Louis Choon Kit Wong, et al.
Published: (2022-12-01)

HIPEC application potential in the treatment of extensive carcinomatosis in ovarian cancer (retrospective study)
by: S. I. Radostev, et al.
Published: (2024-06-01)

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in small bowel adenocarcinoma with peritoneal metastasis: a systematic review
by: Chen Vicky, et al.
Published: (2022-11-01)

Intra-Abdominal Desmoplastic Small Round Cell Tumor (DSRCT) and the Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Review
by: Sophie J. M. Reijers, et al.
Published: (2023-03-01)

Hyperthermic intraperitoneal chemotherapy following up-front cytoreductive surgery versus cytoreductive surgery alone for isolated synchronous colorectal peritoneal metastases: A retrospective, observational study
by: Xiusen Qin, et al.
Published: (2022-10-01)

Advances in the Treatment of Colorectal Cancer with Peritoneal Metastases: A Focus on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
by: Youngbae Jeon, et al.
Published: (2023-12-01)

Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
by: Acs Miklos, et al.
Published: (2024-03-01)

Cytoreductive HIPEC-Combined Surgery in Treatment of Advanced Ovarian Cancer
by: M. V. Zabelin, et al.
Published: (2022-06-01)

EXPERIENCE IN APPLYING THE TECHNOLOGY OF CYTOREDUCTIVE SURGERY WITH HYPERTHERMIC INTRAOPERATIVE INTRAPERITONEAL CHEMOTHERAPY IN THE TREATMENT OF PATIENTS WITH PERITONEAL CARCINOMATOSIS
by: A. V. Shelekhov, et al.
Published: (2018-07-01)

Enhanced recovery after surgery (ERAS) in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a cross-sectional survey
by: Bhandoria Geetu, et al.
Published: (2021-06-01)

Takotsubo Cardiomyopathy After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for a Recurrent Colon Cancer: A Life-Threatening Complication
by: Bogdan Moldovan, et al.
Published: (2024-10-01)

CD8 + T-cells restrict the development of peritoneal metastasis and support the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC)
by: Lilian Roth, et al.
Published: (2024-09-01)

Anesthetic management of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A case series
by: Aswini Lakshminarasimhan, et al.
Published: (2025-11-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases – The Hong Kong experience and literature review
by: Felix Che-lok Chow, et al.
Published: (2021-01-01)

Enhanced recovery after surgery in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: national survey of peri-operative practice by Indian society of peritoneal surface malignancies
by: Somashekhar Sampige Prasanna, et al.
Published: (2023-05-01)

Can baseline quality of life scores predict for morbidity and survival after CRS and HIPEC: a prospective study of 151 patients
by: Chia Claramae Shulyn, et al.
Published: (2022-04-01)

Postoperative leukopenia after cytoreductive surgery and hypertherm intraperitoneal chemotherapy for colorectal carcinomatosis– causes and implication on outcomes in a population-based study
by: Mattias Lepsenyi, et al.
Published: (2025-04-01)

Cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy applications in upper and lower gastrointestinal cancer, a review
by: Denise Drittone, et al.
Published: (2024-11-01)

Early postoperative CRP predicts major complications following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
by: Kartik Akash, et al.
Published: (2023-06-01)

The role of complete cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in ovarian carcinoma: where do we stand today? A comprehensive review and clinical insights from a leading oncology center in India
by: M D Ray, et al.
Published: (2025-06-01)

Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
by: Falla-Zuniga Luis Felipe, et al.
Published: (2023-12-01)

Efficacy and safety of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancer: a systematic review and updated meta-analysis
by: Ahmad Azhar Marzuqi, et al.
Published: (2025-04-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)
by: W. J. Koemans, et al.
Published: (2019-05-01)

Anesthesia Management and Perioperative Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
by: Süheyla Karadağ Erkoç, et al.
Published: (2020-12-01)

The Road to Technical Proficiency in Cytoreductive Surgery for Peritoneal Carcinomatosis: Risk-Adjusted Cumulative Summation Analysis
by: Francesco Santullo, et al.
Published: (2022-05-01)

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in management of peritoneal carcinomatosis: Single center experience in Korea
by: Hee Ju Lee, et al.
Published: (2019-12-01)

Effect of the learning curve of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) on the treatment of colorectal peritoneal metastasis
by: Ezhir Selvan Chidambarasamy, et al.
Published: (2022-01-01)

Editorial: Management of peritoneal surface malignancies. (cytoreductive surgery, HIPEC, PIPAC, and beyond)
by: Amine Souadka, et al.
Published: (2024-03-01)

Immediate postoperative effects of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy using carboplatin on peritoneal tissue inflammatory and ischemic responses: an explorative porcine study
by: Petersen Elisabeth Krogsgaard, et al.
Published: (2025-04-01)

Efficacy and safety of intraperitoneal chemotherapy for pancreatic cancer
by: Dorsa Safari, et al.
Published: (2024-10-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy outcomes in peritoneal carcinomatosis: 11-year tertiary-center experience
by: Burak Dinçer, et al.
Published: (2025-03-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases at an Australian centre
by: Raymond Hayler, et al.
Published: (2025-03-01)

Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?
by: Natasha Leigh, et al.
Published: (2020-06-01)

Perioperative anaesthetic management in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC): a retrospective analysis in a single tertiary care cancer centre
by: Gupta Raghav, et al.
Published: (2022-05-01)

Anaesthetic management and perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: A retrospective analysis
by: Kalpana P Balakrishnan, et al.
Published: (2018-01-01)

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for children and young adults: experience from two high volume centers
by: Eckert Maximilian, et al.
Published: (2025-05-01)

Anesthetic management of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A case report
by: Nilanjana Howbora, et al.
Published: (2023-01-01)

INDEPSO-ISPSM consensus on peritoneal malignancies – Enhanced recovery after surgery in cytoreductive surgery (CRS) with/without hyperthermic intraperitoneal chemotherapy (HIPEC)
by: Geetu Prakash Bhandoria, et al.
Published: (2025-02-01)